Marloes H Maathuis
Overview
Explore the profile of Marloes H Maathuis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scire J, Huisman J, Grosu A, Angst D, Lison A, Li J, et al.
BMC Bioinformatics
. 2023 Aug;
24(1):310.
PMID: 37568078
Background: Accurate estimation of the effective reproductive number ([Formula: see text]) of epidemic outbreaks is of central relevance to public health policy and decision making. We present estimateR, an R...
2.
Huisman J, Scire J, Angst D, Li J, Neher R, Maathuis M, et al.
Elife
. 2022 Aug;
11.
PMID: 35938911
The effective reproductive number is a key indicator of the growth of an epidemic. Since the start of the SARS-CoV-2 pandemic, many methods and online dashboards have sprung up to...
3.
Hiltbrunner S, Spohn M, Wechsler R, Akhoundova D, Bankel L, Kasser S, et al.
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008239
Metastatic non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) may suffer from heavy side effects and not all patients benefit from the treatment. We conducted a...
4.
Mettler S, Park J, Ozbek O, Mettler L, Ho P, Rhim H, et al.
Int J Infect Dis
. 2021 Apr;
108:309-319.
PMID: 33862210
Background: While the role of contact tracing in the containment of the COVID-19 epidemic remains important until vaccines are widely available, literature on objectively measurable indicators for the effectiveness of...
5.
Anderegg N, Hector J, Jefferys L, Burgos-Soto J, Hobbins M, Ehmer J, et al.
J Clin Epidemiol
. 2020 Aug;
128:83-92.
PMID: 32828836
Objectives: People living with human immunodeficiency virus (HIV) on antiretroviral therapy (ART) may be lost to follow-up (LTFU), which hampers the assessment of outcomes. We estimated mortality for patients starting...
6.
Mettler S, Kim J, Maathuis M
Int J Infect Dis
. 2020 Aug;
99:346-351.
PMID: 32771634
Background: The clinical onset serial interval is often used as a proxy for the transmission interval of an infectious disease. For SARS-CoV-2/COVID-19, data on clinical onset serial intervals is limited,...
7.
Baranczuk Z, Estill J, Blough S, Meier S, Merzouki A, Maathuis M, et al.
J Int AIDS Soc
. 2019 Dec;
22(12):e25437.
PMID: 31854506
Introduction: Socio-behavioural factors may contribute to the wide variance in HIV prevalence between and within sub-Saharan African (SSA) countries. We studied the associations between socio-behavioural variables potentially related to the...
8.
Frohlich H, Balling R, Beerenwinkel N, Kohlbacher O, Kumar S, Lengauer T, et al.
BMC Med
. 2018 Aug;
16(1):150.
PMID: 30145981
Background: Personalized, precision, P4, or stratified medicine is understood as a medical approach in which patients are stratified based on their disease subtype, risk, prognosis, or treatment response using specialized...
9.
Kassraian-Fard P, Matthis C, Balsters J, Maathuis M, Wenderoth N
Front Psychiatry
. 2016 Dec;
7:177.
PMID: 27990125
Most psychiatric disorders are associated with subtle alterations in brain function and are subject to large interindividual differences. Typically, the diagnosis of these disorders requires time-consuming behavioral assessments administered by...
10.
Stekhoven D, Moraes I, Sveinbjornsson G, Hennig L, Maathuis M, Buhlmann P
Bioinformatics
. 2012 Sep;
28(21):2819-23.
PMID: 22945788
Genotypic causes of a phenotypic trait are typically determined via randomized controlled intervention experiments. Such experiments are often prohibitive with respect to durations and costs, and informative prioritization of experiments...